Delivery Order SPE2DR25D2002-SPE2DR26FBRU5
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Savella 50 mg tablets (60-count units) under a firm fixed-price contract. The order, valued at $1,412.55, is set to be completed by August 25, 2025, and will be fulfilled from the contractor's Conshohocken, Pennsylvania facility. This delivery order represents a non-set-aside, competitively awarded procurement and serves as a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $2,111.57 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Savella 100 mg, a neurological medication used in pain management. This competitive contract, issued on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a firm fixed price delivery order with no set-aside designation. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a $1,092.15 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Savella 50 mg tablets (60-count packages). This firm fixed-price, non-set-aside contract will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. The delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreement with the DLA....
- The Defense Logistics Agency awarded a $1,580.37 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Savella (milnacipran) 50 mg tablets in a 60-count quantity. This firm fixed-price delivery order, with an ultimate completion date of September 8, 2025, represents a competitively awarded, non-set-aside contract for pharmaceutical procurement. The medication will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Savella 50 mg tablets (60-count units) on August 22, 2025, with a ceiling value of $8,031.09 and an ultimate completion date of August 25, 2025. This non-set-aside, firm fixed-price contract is classified as a delivery order, indicating it falls under a larger indefinite delivery vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,152.26 to AmerisourceBergen Drug Corp for the supply of Savella 25 mg tablets (60-count) on October 29, 2025, with an ultimate completion date of October 30, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December...
- The Defense Logistics Agency awarded a delivery order valued at $18,324.20 to AmerisourceBergen Drug Corp for the supply of Savella (milnacipran) 100 mg tablets in quantities of 60 units. This competitively awarded, firm fixed-price contract has an ultimate completion date of August 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Savella 100 mg, valued at $5,835.91, with an ultimate completion date of October 28, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as one of the nation's largest pharmaceutical...
- The Defense Logistics Agency awarded a $1,892.67 firm fixed price delivery order to AmerisourceBergen Drug Corp for Savella 25 mg tablets (60 count) on November 6, 2025, with completion targeted for November 7, 2025. This non-set-aside contract was awarded competitively to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal medical supply needs, consistent with...
- This delivery order, issued by the Defense Logistics Agency (DLA), awards AmerisourceBergen Drug Corp a $6.38K contract for Savella 100 mg tablets (60-count units) with a completion date of August 12, 2025. The contract, which was competitively awarded with no set-aside designation, utilizes firm fixed pricing and represents a direct pharmaceutical supply fulfillment under DLA's medical procurement framework. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- SPE2DR25D2002Indefinite Delivery Contract
- SPE2DR25D2002-SPE2DR26FBRU5Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Savella 50 mg tablets in quantities of 60 units, with a contract ceiling value of $1,231.64. This is a firm fixed price delivery order with an ultimate completion date of November 12, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract carries no set-aside designation, indicating it was competitively awarded. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a billion-dollar vehicle valued at $999,999,999.00 that runs through December 2026 and serves as the company's primary mechanism for supplying pharmaceutical products and medical supplies to federal healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, regularly fulfills federal medical procurement needs through the DLA Medical Supply Chain. The company's contract portfolio demonstrates extensive experience delivering a broad range of therapeutic products including specialty medications, brand-name and generic pharmaceuticals, vaccines, and medical devices to support military healthcare programs and other federal health systems. This particular delivery order for Savella, a medication used in pain management and neurological treatment, exemplifies the routine pharmaceutical supply transactions executed under the company's IDC framework that sustains federal medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 11/10/25 |